SPBC19C7.11 Antibody

What is SPBC19C7.11 and what role does it play in fission yeast?

SPBC19C7.11 is a gene locus in Schizosaccharomyces pombe (fission yeast) that likely encodes a protein involved in cellular processes similar to other characterized S. pombe proteins. While specific information about this particular gene product is limited in the search results, fission yeast systematic gene naming follows the pattern "SPx" (species identifier), followed by chromosome number (BC = chromosome 2), cosmid number (19C7), and the ORF number (11) on that cosmid . Antibodies against such proteins are essential tools for studying their expression, localization, and function in various cellular processes. The protein may be involved in gene regulation pathways similar to other characterized S. pombe proteins such as those in the Dicer pathway or phosphatase complexes .

What detection methods are compatible with fission yeast antibodies?

Fission yeast antibodies can be utilized across multiple experimental applications:

When working with fission yeast proteins, researchers commonly use techniques such as western blotting for protein detection using peroxidase-anti-peroxidase soluble complexes for TAP-tagged proteins or specific monoclonal antibodies for epitope-tagged versions . The appropriate dilution should be empirically determined for each application to optimize signal-to-noise ratio.

How are fission yeast proteins typically tagged for antibody detection?

Fission yeast proteins are commonly tagged using PCR-based homologous recombination approaches. In published methodologies, genes are tagged with epitopes such as HA or TAP using vectors like pFA6a-3HA-kanMX6, followed by transformation via electroporation . Transformants are selected based on antibiotic resistance (typically kanamycin), and successful integration is confirmed by PCR verification . This approach enables detection of the protein of interest using commercially available antibodies against the tag rather than requiring development of protein-specific antibodies. For SPBC19C7.11, this would involve designing primers with homology to the target gene and the tagging vector.

How can I validate the specificity of an antibody against SPBC19C7.11?

Rigorous validation of antibody specificity is critical for reliable research outcomes. For SPBC19C7.11 antibody, consider implementing this comprehensive validation protocol:

• Genetic validation: Compare antibody signal between wild-type and deletion strains (SPBC19C7.11Δ). A specific antibody should show signal in wild-type cells and no signal in the deletion strain .

• Western blot analysis: Verify that the antibody detects a band of the expected molecular weight. For phosphorylated proteins, compare phosphatase-treated and untreated samples to confirm specificity for the modified form .

• Immunoprecipitation followed by mass spectrometry: Confirm the identity of the immunoprecipitated protein through peptide mass fingerprinting.

• Blocking peptide competition: Pre-incubate antibody with the immunizing peptide prior to immunostaining or western blotting; specific signals should be abolished .

• Cross-reactivity assessment: Test the antibody against related fission yeast proteins to ensure specificity, particularly if SPBC19C7.11 belongs to a protein family with high sequence homology.

What are the key considerations for RIP-chip experiments using SPBC19C7.11 antibody?

When performing RNA-immunoprecipitation coupled with microarray analysis (RIP-chip) using SPBC19C7.11 antibody, several critical factors must be addressed:

• Crosslinking conditions: Optimize formaldehyde concentration (typically 1-3%) and crosslinking time to balance efficient protein-RNA capture with antibody epitope preservation.

• Antibody selection: For tagged proteins, use high-affinity antibodies against the tag (e.g., monoclonal antibodies against protein A for TAP-tagged proteins or 9E11 monoclonal for myc-tagged proteins) .

• Control experiments: Include puromycin treatments (1 mM final concentration) to differentiate between direct RNA binding and co-purification of nascent peptide-associated RNA . Also perform immunoprecipitation with an unrelated antibody of the same isotype.

• RNA extraction and quality control: Carefully purify RNA from immunoprecipitates using established acid phenol extraction methods followed by cleanup with commercial kits such as RNeasy .

• Microarray analysis: Use appropriate statistical methods for data normalization and identification of significantly enriched transcripts, as exemplified in published approaches using tools like GENESPRING .

How do you distinguish between specific and non-specific interactions in co-immunoprecipitation experiments?

Differentiating specific from non-specific interactions in co-immunoprecipitation studies with SPBC19C7.11 antibody requires rigorous controls and validation steps:

• Negative controls: Include immunoprecipitation with pre-immune serum or IgG from the same species to identify non-specific binding to antibody or beads.

• Reciprocal co-immunoprecipitation: Confirm interactions by immunoprecipitating with antibodies against suspected interacting partners.

• Salt titration: Perform immunoprecipitation washes with increasing salt concentrations (150-500 mM NaCl); specific interactions typically withstand higher salt concentrations.

• Detergent optimization: Test different detergents (NP-40, Triton X-100, CHAPS) to maintain specific interactions while reducing non-specific binding.

• Genetic validation: Verify that the interaction is abolished or reduced when one partner is deleted or mutated.

• Competitive peptide elution: For tagged proteins, specific elution with the tag peptide can reduce background compared to boiling in SDS sample buffer .

What is the optimal protocol for immunofluorescence microscopy using SPBC19C7.11 antibody?

For optimal immunofluorescence microscopy with SPBC19C7.11 antibody in fission yeast, follow this detailed protocol based on established methods:

• Cell fixation: Fix cells in 3.8% paraformaldehyde for preservation of cellular structures while maintaining antibody epitope accessibility .

• Cell wall digestion: Treat with zymolyase or lysing enzymes to create spheroplasts, enabling antibody penetration.

• Permeabilization: Use 0.1% Triton X-100 to permeabilize cells without excessive extraction of cellular components.

• Blocking: Block with 5% BSA or normal serum from the same species as the secondary antibody to reduce non-specific binding.

• Primary antibody incubation: Apply SPBC19C7.11 antibody at optimized dilution (typically starting at 1:50-1:200) , incubating overnight at 4°C.

• Secondary antibody application: Use fluorophore-conjugated secondary antibodies with minimal cross-reactivity to fission yeast proteins.

• Nuclear counterstaining: Apply DAPI (1 μg/ml) to visualize nuclear DNA.

• Controls: Include cells without primary antibody and, ideally, a SPBC19C7.11 deletion strain as controls.

• Imaging parameters: Collect images using consistent parameters across experiments, with appropriate exposure times to prevent saturation .

How can I optimize Western blot conditions for detecting SPBC19C7.11?

Western blot optimization for SPBC19C7.11 detection requires careful attention to multiple parameters:

• Sample preparation: Lyse cells using glass bead disruption in buffer containing protease inhibitors and phosphatase inhibitors if detecting phosphorylated forms.

• Protein separation: Select appropriate acrylamide percentage based on SPBC19C7.11's molecular weight; use gradient gels for better resolution if the exact size is unknown.

• Transfer conditions: Optimize transfer time and voltage for efficient transfer of the target protein size range to nitrocellulose or PVDF membrane.

• Blocking optimization: Test different blocking agents (5% non-fat milk, 5% BSA, commercial blocking buffers) to determine which provides the best signal-to-noise ratio.

• Antibody dilution: Begin with 1:500 dilution for western blotting and adjust based on signal intensity . For phospho-specific detection, BSA is preferable to milk for blocking and antibody dilution.

• Detection method: Choose between chemiluminescence for maximum sensitivity or fluorescent secondary antibodies for quantitative analysis.

• Loading control: Include appropriate loading controls such as actin , which has been successfully used in western blot analyses in fission yeast studies.

What strategies can improve antibody performance in challenging applications?

When working with challenging applications of SPBC19C7.11 antibody, consider these advanced strategies:

• Signal amplification systems: For low-abundance proteins, implement tyramide signal amplification or poly-HRP secondary antibodies to enhance detection sensitivity.

• Epitope retrieval methods: For fixed samples, test antigen retrieval methods such as heat-induced epitope retrieval in citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0).

• Modified blocking strategies: Add 0.1% Tween-20 and 5% normal serum from the secondary antibody species to reduce background in immunostaining.

• Monovalent Fab fragments: Pre-block with unconjugated Fab fragments when using multiple antibodies from the same species to prevent cross-reactivity.

• Antibody purification: Consider affinity purification against the immunizing peptide if the antibody shows non-specific binding .

• Storage and handling: Store antibody aliquots at -20°C for long-term stability , avoiding repeated freeze-thaw cycles.

• Specialized buffers: For phospho-epitopes, include phosphatase inhibitors (2 mM sodium orthovanadate, 5 mM sodium fluoride) in all buffers.

How can I address weak or absent signal when using SPBC19C7.11 antibody?

When confronted with weak or absent signal when using SPBC19C7.11 antibody, systematically test these potential solutions:

• Antibody concentration: Increase antibody concentration incrementally, testing dilutions from 1:200 to 1:50 for immunostaining or 1:1000 to 1:250 for western blotting .

• Epitope accessibility: For western blots, test both reducing and non-reducing conditions as disulfide bonds may affect epitope structure.

• Protein extraction method: Compare different lysis methods (detergent-based, mechanical disruption, or combinations) to ensure efficient extraction of SPBC19C7.11.

• Expression level verification: Confirm that SPBC19C7.11 is expressed under your experimental conditions using RT-PCR or RNA-seq data.

• Detection system sensitivity: Switch to a more sensitive detection system, such as enhanced chemiluminescence substrates with longer signal duration.

• Incubation parameters: Extend primary antibody incubation time to overnight at 4°C to increase binding opportunity without increasing background.

• Alternative antibody: If available, test a different antibody that recognizes a different epitope of SPBC19C7.11.

What approaches can detect interactions between SPBC19C7.11 and partner proteins?

To investigate protein-protein interactions involving SPBC19C7.11, consider these complementary approaches:

• Co-immunoprecipitation: Use SPBC19C7.11 antibody to precipitate the protein complex, followed by western blotting for suspected interacting partners .

• Proximity ligation assay (PLA): Detect protein interactions in situ with high sensitivity using antibodies against SPBC19C7.11 and its potential interacting partners.

• Bimolecular Fluorescence Complementation (BiFC): Express SPBC19C7.11 and candidate partners as fusion proteins with complementary fragments of a fluorescent protein.

• FRET/FLIM analysis: Measure Förster resonance energy transfer between fluorescently tagged SPBC19C7.11 and partner proteins to detect interactions within 10 nm.

• Cross-linking mass spectrometry: Use chemical cross-linkers followed by immunoprecipitation and mass spectrometry to identify interaction partners.

• Yeast two-hybrid screening: While this is an artificial system, it can provide candidates for further validation with the methods above.

• Genetic interaction studies: Analyze synthetic lethality or rescue between SPBC19C7.11 and candidate interacting genes .

How can I interpret contradictory results between different antibody-based methods?

When faced with discrepancies between different antibody-based methods when studying SPBC19C7.11, consider these analytical approaches:

• Epitope accessibility differences: Different techniques expose different epitopes; western blotting detects denatured epitopes while immunofluorescence and immunoprecipitation access native conformations.

• Post-translational modification interference: Phosphorylation, methylation, or other modifications may mask epitopes in certain contexts but not others.

• Sample preparation effects: Harsh fixation methods may destroy certain epitopes while preserving others.

• Antibody cross-reactivity: Validate specificity in each experimental context using appropriate controls such as deletion strains.

• Method-specific artifacts: Western blotting may detect aggregated forms not seen in native immunoprecipitation; conversely, IP may detect transient interactions not captured in fixed samples.

• Context-dependent expression: Compare expression levels between experimental conditions using transcriptome data from microarray analysis .

• Technical validation: Repeat experiments with alternative methods or antibodies targeting different epitopes to confirm results.

How can SPBC19C7.11 antibody be used in ChIP-seq applications?

For chromatin immunoprecipitation sequencing (ChIP-seq) applications with SPBC19C7.11 antibody, implement this optimized workflow:

• Crosslinking optimization: If SPBC19C7.11 is a chromatin-associated protein, optimize formaldehyde concentration (1-3%) and crosslinking time (5-20 minutes) to preserve interactions.

• Chromatin fragmentation: Sonicate chromatin to 200-500 bp fragments using a calibrated protocol with verification by gel electrophoresis.

• Antibody validation: Confirm that SPBC19C7.11 antibody efficiently immunoprecipitates the protein of interest from crosslinked chromatin using western blot.

• Input normalization: Reserve 5-10% of chromatin before immunoprecipitation as input control.

• Immunoprecipitation conditions: Use optimized antibody concentration (typically 2-5 μg per reaction) and incubation conditions (overnight at 4°C).

• Washing stringency: Implement a series of increasingly stringent washes to reduce background while maintaining specific interactions.

• Library preparation and sequencing: Prepare sequencing libraries from immunoprecipitated DNA and input samples following established protocols.

• Data analysis: Identify enriched regions using appropriate peak-calling algorithms, followed by motif analysis and gene ontology enrichment.

What considerations apply when using SPBC19C7.11 antibody for quantitative proteomics?

When incorporating SPBC19C7.11 antibody into quantitative proteomics workflows, address these critical considerations:

• Sample preparation compatibility: Ensure lysis and sample preparation methods preserve protein-protein interactions while remaining compatible with downstream mass spectrometry.

• SILAC labeling: For differential analysis, consider stable isotope labeling with amino acids in cell culture (SILAC) approaches for S. pombe.

• Immunoprecipitation efficiency: Optimize antibody amounts and binding conditions to ensure complete immunoprecipitation for accurate quantification.

• On-bead digestion: Consider direct tryptic digestion of immunoprecipitated complexes on beads to minimize sample loss.

• Label-free quantification: Implement appropriate normalization methods and statistical analysis for label-free quantitative comparisons.

• Controls for non-specific binding: Include immunoprecipitation with non-specific IgG and, if possible, from cells lacking SPBC19C7.11 expression.

• Biological replicates: Perform at least three biological replicates to enable statistical analysis of differential protein associations.

• Validation of key findings: Confirm important interactions using orthogonal methods such as western blotting or reciprocal immunoprecipitation.

How can SPBC19C7.11 antibody contribute to studying protein dynamics and modifications?

To investigate dynamic aspects of SPBC19C7.11 function and regulation using antibody-based approaches:

• Phosphorylation analysis: Use phospho-specific antibodies (if available) or general phospho-detection methods following SPBC19C7.11 immunoprecipitation to study regulation by phosphorylation .

• Cell cycle dynamics: Synchronize fission yeast cultures and collect time points to analyze SPBC19C7.11 expression, localization, and modification status throughout the cell cycle.

• Stress response: Expose cells to various stressors (oxidative, heat shock, nutrient limitation) and monitor changes in SPBC19C7.11 status using the antibody.

• Protein turnover: Combine cycloheximide chase with western blotting to measure protein half-life under different conditions.

• FRAP analysis: If using fluorescently tagged versions, perform fluorescence recovery after photobleaching to measure protein mobility in different cellular compartments.

• Pulse-chase experiments: Use metabolic labeling and immunoprecipitation to track newly synthesized versus existing protein pools.

• Post-translational modification mapping: Combine immunoprecipitation with mass spectrometry to identify modifications and quantify their stoichiometry.